NASDAQ:AEMD Aethlon Medical - AEMD Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Aethlon Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.38 -0.01 (-2.56%) (As of 03/28/2023 05:22 PM ET) Add Compare Share Share Today's Range$0.37▼$0.4050-Day Range$0.37▼$0.7052-Week Range$0.23▼$2.46Volume31,536 shsAverage Volume1.06 million shsMarket Capitalization$8.73 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Aethlon Medical MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.87% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.29Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthDecreasingFrom $0.69 to ($0.55) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.01 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Aethlon Medical. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.87% of the outstanding shares of Aethlon Medical have been sold short.Short Interest Ratio / Days to CoverAethlon Medical has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Aethlon Medical has recently increased by 7.50%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAethlon Medical does not currently pay a dividend.Dividend GrowthAethlon Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AEMD. Previous Next 1.8 News and Social Media Coverage News SentimentAethlon Medical has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Aethlon Medical this week, compared to 0 articles on an average week.Search InterestOnly 1 people have searched for AEMD on MarketBeat in the last 30 days. This is a decrease of -86% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Aethlon Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Aethlon Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.20% of the stock of Aethlon Medical is held by insiders.Percentage Held by InstitutionsOnly 11.86% of the stock of Aethlon Medical is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Aethlon Medical are expected to decrease in the coming year, from $0.69 to ($0.55) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aethlon Medical is -0.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aethlon Medical is -0.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAethlon Medical has a P/B Ratio of 0.35. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Aethlon Medical (NASDAQ:AEMD) StockAethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.Read More Receive AEMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address AEMD Stock News HeadlinesMarch 26, 2023 | americanbankingnews.comAethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.comMarch 20, 2023 | americanbankingnews.comAethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.comMarch 28, 2023 | Stansberry Research (Ad)The gold catalyst we’ve waited forIf you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK. February 17, 2023 | finance.yahoo.comAethlon Medical Third Quarter 2023 Earnings: US$0.12 loss per share (vs US$0.16 loss in 3Q 2022)February 16, 2023 | finance.yahoo.comAnalysts Expect Aethlon Medical, Inc. (NASDAQ:AEMD) To Breakeven SoonFebruary 15, 2023 | finance.yahoo.comAEMD: New CRO to Help Advance Studies; Expanded Team to Facilitate EffortsFebruary 14, 2023 | finance.yahoo.comAethlon Medical, Inc. (NASDAQ:AEMD) Q3 2023 Earnings Call TranscriptFebruary 14, 2023 | finanznachrichten.deAethlon Medical, Inc.: Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate UpdateMarch 28, 2023 | Stansberry Research (Ad)The gold catalyst we’ve waited forIf you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK. January 31, 2023 | finance.yahoo.comAethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023January 30, 2023 | msn.comAethlon stock soars ~40% on pact for Hemopurifier clinical program in cancerJanuary 30, 2023 | marketwatch.comAethlon Medical Shares Soar 66% on NAMSA Clinical Trial ContractJanuary 30, 2023 | finance.yahoo.comAethlon Medical Announces Contract with NAMSA to Advance Hemopurifier Clinical Programs in CancerNovember 16, 2022 | finance.yahoo.comAEMD: Hemopurifier Hemopurifier To Be Studied in a Variety of Solid TumorsNovember 15, 2022 | seekingalpha.comAethlon Medical, Inc. (AEMD) Q2 2022 Earnings Call TranscriptNovember 12, 2022 | msn.comPreview: Aethlon Medical's EarningsNovember 2, 2022 | finance.yahoo.comAethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2022October 18, 2022 | seekingalpha.comAEMD Aethlon Medical, Inc.September 17, 2022 | finance.yahoo.comAethlon Medical, Inc. (AEMD)September 6, 2022 | finance.yahoo.comAethlon Medical to Present at Two Investor Conferences in SeptemberAugust 17, 2022 | finance.yahoo.comAEMD: Positive Results in a Range of Conditions, Including COVID-19 & Monkey PoxAugust 15, 2022 | finance.yahoo.comAethlon Medical, Inc. (NASDAQ:AEMD) Is About To Turn The CornerAugust 10, 2022 | seekingalpha.comAethlon Medical, Inc.'s (AEMD) CEO Chuck Fisher on Q1 2023 Results - Earnings Call TranscriptAugust 10, 2022 | finance.yahoo.comAethlon Medical To Start Lab Studies For Hemopurifier For MonkeypoxAugust 3, 2022 | finance.yahoo.comAethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2022July 28, 2022 | finance.yahoo.comAethlon Medical Announces Publication of Peer-Reviewed Journal Article Describing Hemopurifier Resin Binding of Seven COVID-19 VariantsJuly 11, 2022 | nasdaq.comFDA Approves Aethlon Medical's Protocol Amendment For COVID-19 TrialSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive AEMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address AEMD Company Calendar Last Earnings11/09/2021Today3/28/2023Fiscal Year End3/31/2023Next Earnings (Estimated)6/27/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AEMD CUSIPN/A CIK773910 Webwww.aethlonmedical.com Phone(858) 459-7800FaxN/AEmployees10Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.74) Trailing P/E RatioN/A Forward P/E Ratio0.54 P/E GrowthN/ANet Income$-10,420,000.00 Net MarginsN/A Pretax Margin-102,684.61% Return on Equity-77.32% Return on Assets-66.47% Debt Debt-to-Equity RatioN/A Current Ratio7.46 Quick Ratio7.46 Sales & Book Value Annual Sales$290,000.00 Price / Sales29.54 Cash FlowN/A Price / Cash FlowN/A Book Value$1.10 per share Price / Book0.34Miscellaneous Outstanding Shares22,970,000Free Float22,234,000Market Cap$8.57 million OptionableNot Optionable Beta1.25 Key ExecutivesCharles J. FisherChief Executive Officer & DirectorJames B. FrakesChief Financial Officer, Secretary & Senior VPAnnette MarleauResearch DirectorSteven P. LaRosaChief Medical & Scientific OfficerGuy F. CiprianiDirector, Chief Business Officer & Senior VPKey CompetitorsBluejay DiagnosticsNASDAQ:BJDXNEXGELNASDAQ:NXGLVivos TherapeuticsNASDAQ:VVOSPolyPidNASDAQ:PYPDInspireMDNYSE:NSPRView All CompetitorsInstitutional OwnershipJane Street Group LLCBought 126,160 shares on 2/15/2023Ownership: 0.843%Renaissance Technologies LLCBought 38,264 shares on 2/13/2023Ownership: 0.605%HRT Financial LPBought 103,431 shares on 2/10/2023Ownership: 0.622%View All Institutional Transactions AEMD Stock - Frequently Asked Questions Should I buy or sell Aethlon Medical stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aethlon Medical in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" AEMD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AEMD, but not buy additional shares or sell existing shares. View AEMD analyst ratings or view top-rated stocks. How have AEMD shares performed in 2023? Aethlon Medical's stock was trading at $0.2754 at the beginning of the year. Since then, AEMD stock has increased by 35.4% and is now trading at $0.3729. View the best growth stocks for 2023 here. Are investors shorting Aethlon Medical? Aethlon Medical saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 200,700 shares, an increase of 7.5% from the February 28th total of 186,700 shares. Based on an average daily volume of 986,800 shares, the short-interest ratio is currently 0.2 days. View Aethlon Medical's Short Interest. When is Aethlon Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 27th 2023. View our AEMD earnings forecast. How were Aethlon Medical's earnings last quarter? Aethlon Medical, Inc. (NASDAQ:AEMD) announced its quarterly earnings data on Tuesday, November, 9th. The medical equipment provider reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.02. The medical equipment provider earned $0.13 million during the quarter, compared to analysts' expectations of $0.21 million. During the same period last year, the company earned ($0.15) EPS. What other stocks do shareholders of Aethlon Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aethlon Medical investors own include Amarin (AMRN), Nokia Oyj (NOK), Vaxart (VXRT), VBI Vaccines (VBIV), Nabriva Therapeutics (NBRV), CRISPR Therapeutics (CRSP), Novavax (NVAX), Organigram (OGI), AT&T (T) and Aurora Cannabis (ACB). What is Aethlon Medical's stock symbol? Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD." Who are Aethlon Medical's major shareholders? Aethlon Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Jane Street Group LLC (0.84%), HRT Financial LP (0.62%), Renaissance Technologies LLC (0.60%) and Concourse Financial Group Securities Inc. (0.00%). View institutional ownership trends. How do I buy shares of Aethlon Medical? Shares of AEMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Aethlon Medical's stock price today? One share of AEMD stock can currently be purchased for approximately $0.37. How much money does Aethlon Medical make? Aethlon Medical (NASDAQ:AEMD) has a market capitalization of $8.57 million and generates $290,000.00 in revenue each year. The medical equipment provider earns $-10,420,000.00 in net income (profit) each year or ($0.74) on an earnings per share basis. How can I contact Aethlon Medical? Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The official website for the company is www.aethlonmedical.com. The medical equipment provider can be reached via phone at (858) 459-7800 or via email at susan@sanoonan.com. This page (NASDAQ:AEMD) was last updated on 3/28/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.